Brian L. Brown's Insider Trades & SAST Disclosures
Brian L. Brown's most recent trade in Co-Diagnostics Inc was a trade of 134,167 Restricted Stock Unit done . Disclosure was reported to the exchange on Nov. 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian L. Brown.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2024 | 134,167 | 380,833 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2024 | 134,167 | 460,721 (1%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 1.01 per share. | 23 Nov 2024 | 40,816 | 419,905 (1%) | 0% | 1.0 | 41,224 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 113,334 | 326,554 (1%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 113,334 | 515,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 1.09 per share. | 23 May 2024 | 35,865 | 290,689 (1%) | 0% | 1.1 | 39,093 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 225,000 | 628,334 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 80,834 | 157,070 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 80,834 | 521,666 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 1.32 per share. | 23 May 2023 | 26,057 | 131,013 (0%) | 0% | 1.3 | 34,395 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 225,000 | 602,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 20 Mar 2023 | 3,000 | 76,236 (0%) | 0% | 1.9 | 5,697 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 130,000 | 377,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 59,167 | 247,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 59,167 | 91,423 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 3.47 per share. | 23 Nov 2022 | 18,187 | 73,236 (0%) | 0% | 3.5 | 63,109 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 225,000 | 306,667 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,666 | 40,125 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 21,666 | 81,667 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.99 per share. | 23 May 2022 | 7,869 | 32,256 (0%) | 0% | 5.0 | 39,266 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2021 | 21,667 | 25,143 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 21,667 | 103,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 8.44 per share. | 23 Nov 2021 | 6,684 | 18,459 (0%) | 0% | 8.4 | 56,413 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 100,000 | 125,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 5,000 | 25,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.90 per share. | 24 May 2021 | 1,524 | 3,476 (0%) | 0% | 7.9 | 12,039 | Common Stock |
| Co-Diagnostics Inc | Brian L. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 30,000 | 30,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges